Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance. Vikova V. et al. pp.540 By Angélique Bruyer on February 5, 2019 / News Previous Post Diag2Tec s’attaque au myélome multiple
